Funding for this research was provided by:
the Science Technology Department of Zhejiang Province (2014C03041-1)
National Key R&D Program of China (2016YFC1303200)
National Natural Science Foundation of China (82073160)
Article History
Received: 9 October 2020
Accepted: 26 August 2021
First Online: 3 September 2021
Declarations
:
: The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance the tenets of the Helsinki Declaration, and has been approved by the Ethics Committee of the Second Affiliated Hospital of Zhejiang University School of Medicine (No.2015-023). Written informed consent was obtained from all individuals included in this study. The research related to animal use has been complied with the guidelines of Institutional Animal Care and Use Committee (IACUC). The maximum tumor size must not exceed 20 mm (2.0 cm) and this size was not exceeded at any point during the duration of our study. The Ethics Committee of the Second Affiliated Hospital of Zhejiang University School of Medicine approved the animal experiments.
: Not Applicable.
: The authors declare that they have no competing interests.